Back to Peptides

CJC-1295 vs Ipamorelin

Growth Hormone

CJC-1295 (Mod GRF 1-29) and Ipamorelin work through different mechanisms to boost growth hormone. CJC-1295 is a GHRH analog that tells the pituitary to make more GH, while Ipamorelin is a ghrelin mimetic that triggers GH release pulses. They are most commonly used together as a stack for synergistic GH elevation — the combination produces significantly more GH than either alone.

high Search Demand

Side-by-Side Comparison

AspectCJC-1295Ipamorelin
dosing100-300 mcg SubQ 2-3x daily (no DAC) or 300-1000 mcg 1-2x weekly (with DAC)200-300 mcg SubQ 2-3x daily, typically before bed and/or post-workout
best forSustained GH elevation, anti-aging, body composition (especially with DAC version)Clean GH pulses, sleep improvement, fat loss, recovery — fewest side effects of any GH peptide
stackingThe gold standard GH peptide stack. CJC-1295 amplifies the GH production pipeline while Ipamorelin triggers precise release pulses. Typical stack: CJC-1295 (100 mcg) + Ipamorelin (200 mcg) combined injection, 2-3x daily.
mechanismGHRH analog — stimulates GH synthesis and secretion from somatotroph cellsGhrelin receptor (GHS-R) agonist — triggers GH release pulse without affecting cortisol or prolactin
fda statusNot FDA-approved; research peptideNot FDA-approved; research peptide
side effectsHead rush/flushing after injection, water retention (especially DAC version)Minimal — occasional transient head rush, rarely any other side effects
hormonal effectsIncreases GH and IGF-1; does not significantly affect cortisol or prolactinIncreases GH only — uniquely selective, no cortisol, prolactin, or appetite increase

Verdict

Best used together as a stack. If choosing one: Ipamorelin for cleaner, gentler GH elevation with minimal sides; CJC-1295 for stronger sustained GH support. The combination outperforms either alone.